Patents by Inventor Daniel Smithey

Daniel Smithey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising nanoparticles and a resuspending material
    Patent number: 9724362
    Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug and a poorly aqueous soluble polymer, and a resuspending material selected from the group consisting of hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethylcellulose, and pharmaceutically acceptable salt forms thereof.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: August 8, 2017
    Assignee: Bend Research, Inc.
    Inventors: Warren Kenyon Miller, Daniel Smithey, Benjamin Lee Frankamp, Ralph Tadday
  • PHARMACEUTICAL COMPOSITIONS COMPRISING NANOPARTICLES AND A RESUSPENDING MATERIAL
    Publication number: 20100310663
    Abstract: A pharmaceutical composition comprises nanoparticles comprising a poorly water-soluble drug and a poorly aqueous soluble polymer, and a resuspending material selected from the group consisting of hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethylcellulose, and pharmaceutically acceptable salt forms thereof.
    Type: Application
    Filed: December 5, 2008
    Publication date: December 9, 2010
    Inventors: Warren Kenyon Miller, Daniel Smithey, Benjamin Lee Frankamp, Ralph Tadday
  • Pharmaceutical Compositions with Enhanced Performance
    Publication number: 20080064763
    Abstract: Pharmaceutical compositions of a low-solubility drug and lower alkanoate-, phthalate- and trimellitate esters of hydroxypropyl methyl cellulose and lower alkanoate- and succinate esters of cellulose and methyl cellulose are disclosed that provide enhanced concentrations of the drug in a use environment.
    Type: Application
    Filed: January 23, 2006
    Publication date: March 13, 2008
    Inventors: Walter Babcock, Dwayne Friesen, David Lyon, Warren Miller, Daniel Smithey
  • Sustained release dosage forms of ziprasidone
    Publication number: 20070190129
    Abstract: A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 31, 2004
    Publication date: August 16, 2007
    Inventors: Imran Ahmed, Leah Appel, Walter Babcock, Dwayne Friesen, Scott Herbig, David Lyon, Sheri Shamblin, Ravi Shanker, Daniel Smithey, Steven Sutton, Avinash Thombre, Kenneth Waterman
  • Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers
    Publication number: 20070148232
    Abstract: Solid compositions with improved physical stability comprise an amorphous, low-solubility drug, a poloxamer, and a stabilizing polymer. The compositions provide good physical stability during storage and concentration enhancement of dissolved drug when administered to an aqueous environment of use.
    Type: Application
    Filed: December 20, 2004
    Publication date: June 28, 2007
    Inventors: Marshall Crew, Dwayne Friesen, Warren Miller, Ravi Shanker, Daniel Smithey
  • Pharmaceutical Compositions of Adsorbates of Amorphous Drug
    Publication number: 20070148236
    Abstract: Pharmaceutical compositions comprise a low-solubility drug adsorbed onto a high surface area substrate to form an adsorbate. The compositions in some embodiments include a concentration-enhancing polymer.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 28, 2007
    Inventors: Walter Babcock, Dwayne Friesen, Ravi Shanker, Daniel Smithey, Ralph Tadday
  • Solid compositions of low-solubility drugs and poloxamers
    Publication number: 20070141143
    Abstract: Solid compositions of low-solubility drugs and poloxamers that provide concentration enhancement when administered to an aqueous environment of use are disclosed.
    Type: Application
    Filed: December 20, 2004
    Publication date: June 21, 2007
    Inventors: Daniel Smithey, Dwayne Friesen, Warren Miller, Walter Babcock
  • Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
    Publication number: 20050031693
    Abstract: A pharmaceutical composition comprises a solid adsorbate comprising a drug adsorbed onto a substrate and a lipophilic microphase-forming material. The solid adsorbate may also be co-administered with a lipophilic microphase-forming material to an in vivo use environment. The compositions of the present invention enhance the concentration of drug in a use environment.
    Type: Application
    Filed: August 3, 2004
    Publication date: February 10, 2005
    Inventors: Walter Babcock, Dwayne Friesen, Ravi Shanker, Daniel Smithey